Viewing Study NCT01685333


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
Study NCT ID: NCT01685333
Status: COMPLETED
Last Update Posted: 2022-10-31
First Post: 2012-07-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.
Sponsor: Azidus Brasil
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module